We Conduct First-Class Clinical Trials That Deliver New Therapies, Devices And Diagnostics With Tangible Impacts For People The World Over
Hidradenitis Suppurativa – Adolescents and Adults
Adults who have a diagnosis of moderate to severe hidradenitis suppurativa (HS) may qualify for this clinical research trial and receive investigational injectable medication or placebo.
Age: ≥ 18 years old
Diagnosis of HS ≥ 12 months
HS lesions in ≥ 2 distinct anatomical areas and total lesion count ≥ 5
Inadequate response or intolerance to 28-day course of oral antibiotics
Patients will be asked to visit the clinic about 31 times over approximately 64 weeks. There is no cost to participate, and participants will be reimbursed for their time and travel.
For further information on the study, please follow the link:
